Pricing Log in Create free account

Replimune Group, Inc. (REPL) vs Sarepta Therapeutics, Inc. (SRPT)

Replimune Group, Inc. and Sarepta Therapeutics, Inc. are both Biotechnology companies. Replimune Group, Inc. and Sarepta Therapeutics, Inc. are of similar size ($1.9B and $1.9B). Replimune Group, Inc. has the higher net margin (0.00% vs −5.86%) and the lower return on invested capital (−928.3% vs −2.03%). Across the 13 metrics below, Sarepta Therapeutics, Inc. leads on 9 and Replimune Group, Inc. on 4.

Valuation

Metric REPL SRPT Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.96 9.40
P/B 11.16 1.23 2.13
Price to free cash flow n/m 11.07 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 0.95 9.02
Earnings yield (12.86%) (6.21%) (32.88%)
Free cash flow yield (10.75%) 9.04% (23.13%)

Profitability

Metric REPL SRPT Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% (2.50%) 0.00%
Net margin 0.00% (5.86%) 0.00%
Free cash flow margin 0.00% 9.02% 0.00%
Return on equity (115.80%) (8.05%) (51.96%)
Return on assets (71.01%) (3.44%) (46.06%)
Return on invested capital (928.27%) (2.03%) 0.00%

Growth

Metric REPL SRPT Biotechnology median
Revenue growth (TTM) — (18.95%) 6.76%
EPS growth (last fiscal year) (10.10%) (404.70%) 29.88%
Revenue growth, 5-year CAGR — 32.41% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric REPL SRPT Biotechnology median
Debt to equity 0.59 0.56 0.00
Current ratio 7.11 3.46 4.97
Net debt to EBITDA 0.51 0.17 1.01

Dividend

Metric REPL SRPT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric REPL SRPT Biotechnology median
Market cap 1.90b 1.86b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack